Acute respiratory failure in critically ill patients with interstitial lung disease

PLoS One. 2014 Aug 12;9(8):e104897. doi: 10.1371/journal.pone.0104897. eCollection 2014.

Abstract

Background: Patients with chronic known or unknown interstitial lung disease (ILD) may present with severe respiratory flares that require intensive management. Outcome data in these patients are scarce.

Patients and methods: Clinical and radiological features were collected in 83 patients with ILD-associated acute respiratory failure (ARF). Determinants of hospital mortality and response to corticosteroid therapy were identified by logistic regression.

Results: Hospital and 1-year mortality rates were 41% and 54% respectively. Pulmonary hypertension, computed tomography (CT) fibrosis and acute kidney injury were independently associated with mortality (odds ratio (OR) 4.55; 95% confidence interval (95%CI) (1.20-17.33); OR, 7.68; (1.78-33.22) and OR 10.60; (2.25-49.97) respectively). Response to steroids was higher in patients with shorter time from hospital admission to corticosteroid therapy. Patients with fibrosis on CT had lower response to steroids (OR, 0.03; (0.005-0.21)). In mechanically ventilated patients, overdistension induced by high PEEP settings was associated with CT fibrosis and hospital mortality.

Conclusion: Mortality is high in ILD-associated ARF. CT and echocardiography are valuable prognostic tools. Prompt corticosteroid therapy may improve survival.

MeSH terms

  • Acute Disease
  • Adrenal Cortex Hormones / therapeutic use
  • Aged
  • Critical Illness
  • Female
  • Hospital Mortality
  • Humans
  • Logistic Models
  • Lung Diseases, Interstitial / complications*
  • Lung Diseases, Interstitial / therapy
  • Male
  • Middle Aged
  • Paris / epidemiology
  • Positive-Pressure Respiration
  • Respiration, Artificial
  • Respiratory Distress Syndrome / etiology
  • Respiratory Distress Syndrome / mortality
  • Respiratory Distress Syndrome / therapy
  • Respiratory Insufficiency / etiology*
  • Respiratory Insufficiency / mortality
  • Respiratory Insufficiency / therapy
  • Retrospective Studies

Substances

  • Adrenal Cortex Hormones

Grants and funding

The authors have no support or funding to report.